COVID-19 is rising in prevalence in many states nationally following the July 4 holiday week, but the role of the main therapy to treat it—the antiviral drug Paxlovid—is less clear.

The Health and Human Services chief and the growing authoritarianism within the department are already seeding future danger.

MN-166 COMBAT ALS trial down to single digit required enrollment while MN-001 hypertriglyceridemia trial in type 2 diabetes ...

U.S. health secretary Robert F. Kennedy Jr.'s changes to federal vaccine policy are prompting medical organizations and several states to formulate their own vaccine recommendations for the fall ...

Jesús Santamaría has penned crime novels full of death — and received more than $5.8 million from the European Union toward ...

Robert F. Kennedy Jr.’s leadership at Health and Human Services has led to changes in vaccine recommendations and access, sparking concerns among medical experts.

Childhood vaccination rates have markedly declined across the U.S. since the start of the COVID-19 pandemic, according to new ...

The new shots won’t be available until the fall, and are expected to be approved only for adults 65 and up and kids and ...

Thanks to healthcare reform, the hurdles to securing reimbursement and technology add-on payments have risen. Boston will need to invest more in clinical studies to demonstrate superiority of outcomes ...

In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at the FDA, ...